Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiomyolipoma
Research results from A.M. Priola and colleagues update understanding of angiomyolipoma
June 2nd, 2009
"Perivascular epithelioid cell (PEC) tumors (or PEComas) are myomelanocytic lesions defined by coexpression of melanocytic and muscle markers, suggesting dual differentiation. They are rare mesenchymal tumors and include subtypes with distinct clinical features: angiomyolipoma, lymphangioleiomyomatosis, and clear cell ''sugar'' tumors of the lung, pancreas and uterus," investigators in Turin, Italy report. "Consequent upon the World health Organizations recognition of PEC-derived tumors its it distinct entity, an increasing number of reports has documented PEComas arising at various anatomical locations. Clear cell myomelanocytic tumors of the falciform...
Source: Cancer Weekly (2009-06-02)
|
